North Shore Community College is a public community college in Massachusetts with campuses in Danvers, and Lynn. The college offers over 80 associate degree and certificate programs to approximately 10,000 students a year from the 26 cities and towns along the coastal region from north metropolitan Boston to Cape Ann. North Shore Community College is accredited by the New England Commission of Higher Education.
ABSTRACT With their open access mission and the diverse students served, community colleges are poised to lead equitable student success efforts in the academy. Research demonstrates, however, that many community colleges fail to support the success of Students of Color. Equitable student success efforts have become even more challenging due to anti‐DEI rhetoric, actions, and legislation from federal and many state governments. Equity‐mindedness as conceptualized and developed for higher education by Dr. Estela Bensimon provides the framework and tools community colleges need to serve all their students and close racialized disparate student outcomes. This article offers equity‐minded strategies being utilized by community college leaders as they serve students and advance institutional missions.
e23026 Background: Non-inferiority (NI) trials, which investigate if a new treatment is not significantly worse than the standard treatment, are increasingly popular. Selecting an appropriate NI margin is crucial as a larger margin might conceal the inferiority of a treatment option; also, intention-to-treat analyses (ITT)-only analysis can bias results towards demonstrating non-inferiority. Reporting of NI trial design has been inconsistent in the literature, and recent patterns have not clearly delineated. Here we aim to describe trial factors that might influence NI margin reporting. Methods: We searched PubMed, ClinicalTrials.gov, and HemOnc.org for published manuscripts of NI trials from 2015-2025 focusing on systemic therapy comparisons. We then conducted multivariable logistic regression (MLR) to assess the association between NI margin reporting and trial sponsorship, journal tier, analysis type, and trial period. Results: The 93 included studies collectively enrolled 82,638 patients. Of these, 70 (75%) met the primary endpoint of NI of the experimental arm. 56 (60%) did not report a rationale for selecting the NI margin. Among the studies that provided a justification, the rationale was: based on previous literature (57%), author discussion (16%), clinical judgment (8%), or a combination of these factors (13.5%). 47 studies (50.5%) conducted ITT analysis only, 4 (4%) performed per protocol (PP) analysis only, and 42 (45%) conducted both ITT and PP analysis. 46 studies (49%) were published in high-tier journals. Industry sponsorship was noted in 51 studies (55%), while 39 (42%) were supported by government agencies, cooperative groups, or academic institutions. For the 36 studies that proved NI based on the ITT analysis alone, 22 (61%) did not provide any justification for choosing the margin. Of these, 23 (64%) were industry-supported; 15 studies (42%) were multi-national. None of the predictors in MLR analysis reached statistical significance. Conclusions: NI trial design is important for success and interpretation of NI trials; however, our analysis shows most NI trials do not report the rationale for their selected margin, and more than half use ITT-only analysis. No analyzed variable was statistically significant in MLR for the prediction of NI margin reporting, although there was a trend towards an association between ITT-only analysis and non-reporting of margin selection rationale. NI is an appealing means to introduce new treatments, such as biosimilars, for cost-effectiveness, less toxicity, or shorter alternative options. Stricter adherence to guidelines and transparent reporting are needed to ensure the reliability and impact of the NI design. MLR results. Variable OR (95% CI) Industry-sponsored vs not 0.61 (0.25-1.48) Mid/low vs high journal tier 0.82 (0.42-1.57) ITT-only vs PP/both analyses 0.51 (0.23-1.10) Year of publication (2021-2025 vs 2015-2019) 1.42 (0.59-3.47)
e13577 Background: Evidence-based clinical practice guidelines (CPGs) are vital for safe and updated oncology care. ASCO produces CPGs across solid and blood cancers and supportive care. Guideline authors include volunteers and ASCO staff. This study characterizes ASCO CPGs by authorship and their affiliations. Methods: ASCO-only and collaborative CPGs published in peer-reviewed journals, excluding rapid recommendations, were analyzed. CPGs were categorized into 16 clinical groups. Author and institutional data were extracted from PubMed and normalized using Python and manual abstraction. Authors’ gender was determined using gender-guesser, genderAPI, and manual review. Statistical comparisons used Fisher’s exact test. Data were sourced from HemOnc.org on 12/02/2024. Results: We identified 146 eligible CPGs (1999–2024), with 1297 unique authors. 102 (8%) were ever-first authors and 108 (8%) were ever-last (senior) authors. The most prolific first author was in this role six times (breast/classical hematology), while the most prolific last author, five times (breast cancer). A total of 482 institutions were represented, and senior authorship spanned 59 institutions, with 33% affiliated with five institutions: University of Michigan, MD Anderson, Dana-Farber, Johns Hopkins, and ASCO. Only four CPGs had first and senior authors from the same institution. 844 (65%) authors were USA-based. Canada, UK, Italy, Japan, and Netherlands were sequentially the next five highest contributors (142 authors). Top groups included breast (36 CPGs), gastrointestinal (21), and supportive care (20). Immunotoxicity CPGs had the highest collaboration (31 authors/guideline) compared to the lowest in radiotherapy toxicity (11.7 authors/guideline). Over the 25-year publication period, 18 authors transitioned from first to senior authorship, and 48 different authors transitioned from middle to first or senior authorship. Based on algorithmically assigned gender, 57% of all authors, 57% of first authors, and 60% of senior authors were men. Immunotoxicity had the highest representation of women (60%), while radiotherapy toxicity had the lowest (10.5%). Of the 1297 authors, 283 (22%) also contributed to pivotal clinical trials publications supporting regulatory approvals. These authors were more likely to be men (70% men vs 30% women) than the non-contributing authors (53% men vs 47% women) (OR 2.02, 95% CI 1.52–2.68). Conclusions: ASCO CPGs demonstrate broad institutional and international representation, though senior author concentration in a smaller number of institutions was observed. We show gender differences exist in ASCO guideline authorship, although they are significantly less prominent overall than in the subgroup of pivotal clinical trial authors. Future research should explore whether ASCO guideline authorship diversity reflects the demographics of oncology subfields.
Treatment of brain metastases (BMs) in non-small cell lung cancer (NSCLC) has been transformed by CNS-penetrant tyrosine kinase inhibitors (CNS-TKIs) directed at targetable genomic alterations (TGAs). Limited real-world data exist regarding upfront and salvage radiation in these patients. We conducted an IRB-approved retrospective study of consecutive patients with NSCLC BMs treated with SRS between 2017 and 2021. Patients were classified into two cohorts: 1) those with TGAs treated with CNS-TKIs and 2) those without TGAs. Clinical data were extracted from the medical record. Regression analyses were used to assess the relationship between CNS-TKI, use of SRS and WBRT, and presence of leptomeningeal disease (LMD). We identified 158 patients with 353 BMs, with 58 patients in Group 1(G1), and 100 patients in Group 2 (G2). G1 patients had these TGAs: EGFR (n=32), ALK (n=16), ROS1 (n=8), RET (n=2.) Median follow-up was 18 months for G1 and 8 months for G2 (p=0.03). G1 patients received SRS at a median of 224±74 days from BM diagnosis versus 34±17 days in G2 (p=1.9x10-7). Lesions treated in G1 patients were more likely to have been present at BM diagnosis (G1:65%, G2:50%, p=0.029). There was no difference in salvage WBRT use between groups (G1: 13.8% G2: 11%, p=0.60). There was a trend toward more LMD among G1 patients (10/58 (17%) vs. 6/100 (6%), p=0.054). This study represents one of the largest evaluating patterns of brain RT in patients with NSCLC BMs on CNS-TKIs. While these agents delay time to SRS, 65% of lesions needing SRS were present at initial BM diagnosis, suggesting that local progression remains a concern. There was no difference in the use of salvage WBRT, despite higher rates of LMD in G1 patients. Identification of factors predictive of CNS progression may enable optimization of local therapy in conjunction with CNS-TKIs.
Background There is a critical need for evidence-based metacognition instruction models with an ease of implementation. Three issues involved in advancing the implementation and assessment of metacognitive interventions are: (i) the lack of an operational framework for the development of metacognition; (ii) metacognition instruction models that lack a focus on explicitly engaging students’ self-perceptions; (iii) a lack of metacognitive interventions that are easy to implement and require minimal training. This study describes the development and implementation of a 10-week discussion-based module to promote metacognitive development as part of a general chemistry course at a community college. This curricular metacognition instruction model involved the explicit engagement of self-efficacy beliefs in addition to introducing metacognitive awareness and regulation through individual and group reflection. This approach involves a systematic framework which allowed students to confront their beliefs about their abilities, learn various task strategies, and practice these strategies along with their peers. This case study was designed to address the following: can explicit cognitive and metacognitive instruction and discussion serve as a catalyst for students to (1) build and adapt metacognitive knowledge about cognition, and (2) incorporate effective study strategies?. Results Students’ individual and collaborative reflections were analyzed using a thematic analysis. Written journal responses indicate that the module facilitated a shared discourse about cognition where metacognitive awareness was observed shifting from a tacit to explicit awareness. In addition, the framework facilitated the formation of support networks (cognitive and emotional) where students were observed exchanging cognitive strategies and encouraging one another to persevere through challenges. Conclusions Our findings suggest that the metacognitive instruction model described here can serve as a mechanism to encourage student reflection on their beliefs and behaviors. Instructors looking to include metacognition instruction could use the framework presented as a template. The discussion-based module is embedded in the curriculum, delivered through the course management system, and has a low barrier to implementation.